Tanai Therapeutics SA
Tanai Therapeutics reported total assets of €3.87m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 May 2026).
By total assets for 2025, Tanai Therapeutics ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Tanai Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tanai Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 May 2026
- Year ended 31 Dec 2024filed on 03 Jun 2025
Tanai Therapeutics's financial analysis
- Solvency91.8%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tanai Therapeutics
Tanai Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.228.546
- VAT number
- BE1002228546
- Peppol
- Registered · 0208:1002228546 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 13 Nov 2023
- Registered office
- 9051 Ghent
- Latest accounts
- 2025 · filed on 22 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Tanai Therapeutics (SA) has been based in Ghent since 2023, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €2.49m and equity of €3.56m; its revenue is not published. Its solvency stands at 91.8%, above the median of its sector (61.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Tanai Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Genflow Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.74m
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Wishbone Research and experimental development on natural sciences and engineering Flémalle · balance sheet €3.39m
- Ipratech Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.29m
- Bio-Sourcing Research and experimental development on natural sciences and engineering Liège · balance sheet €6.59m
- Amyl Therapeutics Research and experimental development on natural sciences and engineering Liège · balance sheet €7.02m
- Bioxodes Research and experimental development on natural sciences and engineering Charleroi · balance sheet €7.68m
Frequently asked questions about Tanai Therapeutics
What is the revenue of Tanai Therapeutics?
Tanai Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tanai Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE1002228546 for Tanai Therapeutics, if the company is VAT-registered. Its company number (CBE) is 1002.228.546.
Where is the registered office of Tanai Therapeutics?
According to the CBE register, the registered office of Tanai Therapeutics is in 9051 Ghent.
What is the equity of Tanai Therapeutics?
At the close of the 2025 financial year, the equity of Tanai Therapeutics amounts to 3,556,903 €, a solvency of 91.8% of total assets.
Who manages Tanai Therapeutics?
The register lists 6 active mandates at Tanai Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Tanai Therapeutics within its sector?
By total assets for 2025, Tanai Therapeutics ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Tanai Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →